SINGAPORE—Intense research has been performed on tocotrienol over the past 20 years. This includes numerous investigations into cardiovascular health, cancer, antioxidants, angiogenesis, neurodegeneration, anti-aging and more.
Dr. Lee C. Smith, Chief Executive Officer, Davos Life Science Pte Ltd, will review the research in a VendorWorks presentation on Nov. 12, from 4:30–5:20 p.m. at SupplySide West, Nov. 11-13 in Las Vegas.
Dr. Smith will review the status of tocotrienol with respect to where the R&D has come from, where its health applications are going, and the potential for tocotrienol use in supplements, functional foods/drinks, cosmetics/personal care, as well as in the pharmaceutical area.